| __timestamp | Ionis Pharmaceuticals, Inc. | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 241751000 | 242549000 |
| Thursday, January 1, 2015 | 322292000 | 245098000 |
| Friday, January 1, 2016 | 344320000 | 147600000 |
| Sunday, January 1, 2017 | 374644000 | 264600000 |
| Monday, January 1, 2018 | 414604000 | 357900000 |
| Tuesday, January 1, 2019 | 466000000 | 1182600000 |
| Wednesday, January 1, 2020 | 535000000 | 357700000 |
| Friday, January 1, 2021 | 643000000 | 540100000 |
| Saturday, January 1, 2022 | 833000000 | 322900000 |
| Sunday, January 1, 2023 | 899625000 | 408000000 |
| Monday, January 1, 2024 | 901530000 |
Unveiling the hidden dimensions of data
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Ionis Pharmaceuticals, Inc. and United Therapeutics Corporation have been at the forefront of this race. From 2014 to 2023, Ionis Pharmaceuticals consistently outpaced United Therapeutics in R&D investment, with an average annual increase of approximately 12%. Notably, in 2023, Ionis allocated nearly 900 million dollars to R&D, marking a 270% increase from 2014. In contrast, United Therapeutics' R&D spending peaked in 2019, with a significant 1.18 billion dollars, but has since seen fluctuations. This trend highlights Ionis' steady commitment to innovation, while United Therapeutics shows a more variable investment pattern. As the biotech industry evolves, these financial commitments underscore the strategic priorities of each company in driving future breakthroughs.
Analyzing R&D Budgets: Sanofi vs United Therapeutics Corporation
Gilead Sciences, Inc. or United Therapeutics Corporation: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Vertex Pharmaceuticals Incorporated vs United Therapeutics Corporation
Regeneron Pharmaceuticals, Inc. or United Therapeutics Corporation: Who Invests More in Innovation?
Research and Development Expenses Breakdown: United Therapeutics Corporation vs Apellis Pharmaceuticals, Inc.
United Therapeutics Corporation or PTC Therapeutics, Inc.: Who Invests More in Innovation?
Analyzing R&D Budgets: United Therapeutics Corporation vs MorphoSys AG
United Therapeutics Corporation or Vericel Corporation: Who Invests More in Innovation?
United Therapeutics Corporation or Ligand Pharmaceuticals Incorporated: Who Invests More in Innovation?
Ionis Pharmaceuticals, Inc. or Ultragenyx Pharmaceutical Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Ionis Pharmaceuticals, Inc. and CRISPR Therapeutics AG
Comparing Innovation Spending: Ionis Pharmaceuticals, Inc. and Arrowhead Pharmaceuticals, Inc.